- Amended Statement of Ownership (SC 13G/A)
09 1월 2009 - 7:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
VANDA PHARMACEUTICALS INC.
(Name of Issuer)
Common Stock, par value $0.001
(Title of Class of Securities)
December 31, 2008
(Date of Event which Requires Filing
of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
o
|
|
Rule 13d-1(b)
|
|
þ
|
|
Rule 13d-1(c)
|
|
o
|
|
Rule 13d-1(d)
|
*
The remainder of this cover page shall be filled out for a reporting persons initial
filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be
filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or
otherwise subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act (however, see the Notes).
Page 1 of 12
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
921659108
|
13G
|
Page
|
|
2
|
|
of
|
|
12
|
Pages
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
S.A.C. Capital Advisors, LLC
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
(a)
o
|
|
(b)
þ
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Delaware
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
NUMBER OF
|
|
0
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
BENEFICIALLY
|
|
|
OWNED
|
|
0 (see Item 4)
|
|
|
|
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
|
0
|
|
|
|
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
0 (see Item 4)
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
0 (see Item 4)
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0% (see Item 4)
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
00
|
*SEE INSTRUCTION BEFORE FILLING OUT
Page 2 of 12
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
921659108
|
13G
|
Page
|
|
3
|
|
of
|
|
12
|
Pages
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
S.A.C. Capital Management, LLC
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
(a)
o
|
|
(b)
þ
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Delaware
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
NUMBER OF
|
|
0
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
BENEFICIALLY
|
|
|
OWNED BY
|
|
0 (see Item 4)
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
REPORTING
|
|
|
PERSON
|
|
0
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
0 (see Item 4)
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
0 (see Item 4)
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0% (see Item 4)
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
00
|
*SEE INSTRUCTION BEFORE FILLING OUT
Page 3 of 12
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
921659108
|
13G
|
Page
|
|
4
|
|
of
|
|
12
|
Pages
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
S.A.C. Capital Associates, LLC
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
(a)
o
|
|
(b)
þ
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Anguilla, British West Indies
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
NUMBER OF
|
|
0
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
BENEFICIALLY
|
|
|
OWNED BY
|
|
0 (see Item 4)
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
REPORTING
|
|
|
PERSON
|
|
0
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
0 (see Item 4)
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
0 (see Item 4)
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0% (see Item 4)
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
00
|
*SEE INSTRUCTION BEFORE FILLING OUT
Page 4 of 12
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
921659108
|
13G
|
Page
|
|
5
|
|
of
|
|
12
|
Pages
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
CR Intrinsic Investors, LLC
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
(a)
o
|
|
(b)
þ
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Delaware
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
NUMBER OF
|
|
0
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
BENEFICIALLY
|
|
|
OWNED BY
|
|
0 (see Item 4)
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
REPORTING
|
|
|
PERSON
|
|
0
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
0 (see Item 4)
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
0 (see Item 4)
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0% (see Item 4)
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
00
|
*SEE INSTRUCTION BEFORE FILLING OUT
Page 5 of 12
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
921659108
|
13G
|
Page
|
|
6
|
|
of
|
|
12
|
Pages
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
CR Intrinsic Investments, LLC
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
(a)
o
|
|
(b)
þ
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
Anguilla, British West Indies
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
NUMBER OF
|
|
0
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
BENEFICIALLY
|
|
|
OWNED BY
|
|
0 (see Item 4)
|
|
|
|
|
EACH
|
7
|
|
SOLE DISPOSITIVE POWER
|
REPORTING
|
|
|
PERSON
|
|
0
|
|
|
|
|
WITH
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
0 (see Item 4)
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
0 (see Item 4)
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0% (see Item 4)
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
00
|
*SEE INSTRUCTION BEFORE FILLING OUT
Page 6 of 12
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
|
|
921659108
|
13G
|
Page
|
|
7
|
|
of
|
|
12
|
Pages
|
|
|
|
|
|
|
1
|
|
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steven A. Cohen
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
|
(a)
o
|
|
(b)
þ
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
United States
|
|
|
|
|
|
5
|
|
SOLE VOTING POWER
|
|
|
|
NUMBER OF
|
|
0
|
|
|
|
|
SHARES
|
6
|
|
SHARED VOTING POWER
|
BENEFICIALLY
|
|
|
OWNED
|
|
0 (see Item 4)
|
|
|
|
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
|
|
|
|
0
|
|
|
|
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
0 (see Item 4)
|
|
|
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
0 (see Item 4)
|
|
|
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
|
|
o
|
|
|
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
|
0% (see Item 4)
|
|
|
|
12
|
|
TYPE OF REPORTING PERSON*
|
|
|
|
IN
|
*SEE INSTRUCTION BEFORE FILLING OUT
Page 7 of 12
TABLE OF CONTENTS
Item 1(a)
Name of Issuer
:
|
|
Vanda Pharmaceuticals Inc.
|
Item 1(b)
Address of Issuers Principal Executive Offices
:
|
|
9605 Medical Center Drive, Suite 300, Rockville, Maryland 20850
|
Items 2(a)
Name of Person Filing:
|
|
This statement is filed by: (i) S.A.C. Capital Advisors, LLC (SAC
Capital Advisors) with respect to Issuers Common Stock, par value
$0.001 (the Shares), beneficially owned by S.A.C. Capital Associates,
LLC (SAC Capital Associates) and S.A.C. MultiQuant Fund, LLC (SAC
MultiQuant Fund); (ii) S.A.C. Capital Management, LLC (SAC Capital
Management) with respect to Shares beneficially owned by SAC Capital
Associates and SAC MultiQuant Fund; (iii) SAC Capital Associates with
respect to Shares beneficially owned by it; (iv) CR Intrinsic
Investors, LLC (CR Intrinsic Investors) with respect to Shares
beneficially owned by CR Intrinsic Investments, LLC (CR Intrinsic
Investments); (v) CR Intrinsic Investments with respect to Shares
beneficially owned by it, and (vi) Steven A. Cohen with respect to
Shares beneficially owned by SAC Capital Advisors, SAC Capital
Management, SAC Capital Associates, SAC MultiQuant Fund, CR Intrinsic
Investors and CR Intrinsic Investments.
|
Item 2(b)
Address of Principal Business Office
:
|
|
The address of the principal business office of (i) SAC Capital Advisors, CR Intrinsic Investors
and Mr. Cohen is 72 Cummings Point Road, Stamford, Connecticut 06902, (ii) SAC Capital Management
is 540 Madison Avenue, New York, New York 10022, (iii) SAC Capital Associates is P.O. Box 58,
Victoria House, The Valley, Anguilla, British West Indies and (iv) CR Intrinsic Investments is Box
174, Mitchell House, The Valley, Anguilla, British West Indies.
|
Page 8 of 12
Item 2(c)
Citizenship
:
|
|
SAC Capital Advisors, SAC Capital Management and CR Intrinsic Investors
are Delaware limited liability companies. SAC Capital Associates and
CR Intrinsic Investments are Anguillan limited liability companies.
Mr. Cohen is a United States citizen.
|
Item 2(d)
Title of Class of Securities
:
|
|
Common Stock, par value $0.001
|
Item 2(e)
CUSIP Number
:
Item 3
Not Applicable
Item 4
Ownership
:
|
|
As of the close of business on December 31, 2008:
|
|
|
|
1. S.A.C. Capital Advisors, LLC
(a) Amount beneficially owned: -0-
(b) Percent of class: 0%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: -0-
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: -0-
|
|
|
|
2. S.A.C. Capital Management, LLC
(a) Amount beneficially owned: -0-
(b) Percent of class: 0%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: -0-
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: -0-
|
|
|
|
3. S.A.C. Capital Associates, LLC
(a) Amount beneficially owned: -0-
|
Page 9 of 12
|
|
(b) Percent of class: 0%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: -0-
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: -0-
|
|
|
|
4. CR Intrinsic Investors, LLC
(a) Amount beneficially owned: -0-
(b) Percent of class: 0%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: -0-
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: -0-
|
|
|
|
5. CR Intrinsic Investments, LLC
(a) Amount beneficially owned: -0-
(b) Percent of class: 0%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: -0-
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: -0-
|
|
|
|
6. Steven A. Cohen
(a) Amount beneficially owned: -0-
(b) Percent of class: 0%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: -0-
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: -0-
|
|
|
SAC Capital Advisors, SAC Capital Management, CR Intrinsic Investors
and Mr. Cohen do not directly own any Shares. Pursuant to investment
agreements in effect at the time, each of SAC Capital Advisors and SAC
Capital Management shared all investment and voting power with respect
to the securities held by SAC Capital Associates and SAC MultiQuant
Fund. Pursuant to an investment management agreement, CR Intrinsic
Investors maintains investment and voting power with respect to the
securities held by CR Intrinsic Investments. Mr. Cohen controls each
of SAC Capital Advisors, SAC Capital Management and CR Intrinsic
Investors. CR Intrinsic Investments is a wholly owned subsidiary of
SAC Capital Associates. Each of SAC Capital Advisors, SAC Capital
Management, CR Intrinsic Investors and Mr. Cohen disclaim beneficial
ownership of any of the securities covered by this statement, and SAC
Capital Associates
|
Page 10 of 12
|
|
disclaims beneficial ownership of any securities held by CR Intrinsic
Investments.
|
Item 5
Ownership of Five Percent or Less of a Class
:
|
|
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the
following.
þ
|
Item 6
Ownership of More than Five Percent on Behalf of Another Person
:
Item 7
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
:
Item 8
Identification and Classification of Members of the Group
:
Item 9
Notice of Dissolution of Group
:
Item 10
Certification
:
By signing below the signatory certifies that, to the best of his knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction having that purpose or
effect.
Page 11 of 12
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the
information set forth in this statement is true, complete and correct.
|
|
|
|
|
Dated:
|
|
January 8, 2009
|
|
|
|
|
|
|
|
S.A.C. CAPITAL ADVISORS, LLC
|
|
|
|
|
|
|
|
By:
Name:
|
|
/s/ Peter Nussbaum
Peter Nussbaum
|
|
|
Title:
|
|
Authorized Person
|
|
|
|
|
|
|
|
S.A.C. CAPITAL MANAGEMENT, LLC
|
|
|
|
|
|
|
|
By:
Name:
|
|
/s/ Peter Nussbaum
Peter Nussbaum
|
|
|
Title:
|
|
Authorized Person
|
|
|
|
|
|
|
|
S.A.C. CAPITAL ASSOCIATES, LLC
|
|
|
|
|
|
|
|
By:
Name:
|
|
/s/ Peter Nussbaum
Peter Nussbaum
|
|
|
Title:
|
|
Authorized Person
|
|
|
|
|
|
|
|
CR INTRINSIC INVESTORS, LLC
|
|
|
|
|
|
|
|
By:
Name:
|
|
/s/ Peter Nussbaum
Peter Nussbaum
|
|
|
Title:
|
|
Authorized Person
|
|
|
|
|
|
|
|
CR INTRINSIC INVESTMENTS, LLC
|
|
|
|
|
|
|
|
By:
Name:
|
|
/s/ Peter Nussbaum
Peter Nussbaum
|
|
|
Title:
|
|
Authorized Person
|
|
|
|
|
|
|
|
STEVEN A. COHEN
|
|
|
|
|
|
|
|
By:
Name:
|
|
/s/ Peter Nussbaum
Peter Nussbaum
|
|
|
Title:
|
|
Authorized Person
|
|
|
Page 12 of 12
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024